Skip to content

Effects of Exercise and Virtual Reality on Depression

Effects of Exercise With Virtual Reality on Females and Males With or Without Depression

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05973461
Enrollment
200
Registered
2023-08-02
Start date
2022-05-17
Completion date
2027-08-31
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptoms of Depression

Brief summary

This study is evaluating the effects of riding on a cycle ergometer while experiencing virtual reality to determine its effect on mood.

Detailed description

Adults (males and females) above the age of 18 yrs will be recruited to determine if they have symptoms of depression based on a questionnaire (Center for Epidemiologic Studies - Depression Scale (CES-D). They will then complete a Beck Inventory before and after the exercise. Participants will be divided into groups either having symptoms of depression or not. They will be randomized to ride on a cycle ergometer with or without using Virtual Reality (VR) that will allow them to view neighborhoods or parks during the exercise. The ergometer will be set at resistance raising the heart rate to 65% of their age-predicted heart rate maximum. They will ride for 20 min and then complete the Beck Inventory to determine any changes in their depressive symptoms.

Interventions

DEVICEExercise and virtual reality

Riding a cycle ergometer while experiencing virtual reality

OTHERRiding a cycle ergometer

Riding on a cycle ergometer without experiencing virtual reality

Sponsors

The University of Texas at Arlington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Intervention model description

males and females, with and without symptoms of depression

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Males and females over the age of 18 years * With or without symptoms of depression * Physically inactive or sedentary (less than 30 minutes per day) * Normal vision and no color blindness * No physical disorders such as walking with assistance

Exclusion criteria

* Below the age of 18 years or over 65 years, * Women who are pregnant * Individuals who have been diagnosed with mental disorders * Individuals with leg injuries * Individuals with cardiac problems * Individuals with a history of asthma * Individuals with a body mass index over 30.

Design outcomes

Primary

MeasureTime frameDescription
Beck Depression Inventory Scale of Measurement5 minutesAssessment of symptoms of depression pre and post-intervention cycle exercise. The Beck Depression Inventory is a 21-item, multiple-choice, self-report survey that measures characteristic attitudes and symptoms of depression. The score range is 0-63. The higher the score the more severe the depression. Scores above 41 are considered "extreme depression."
Spatial Working Memory (SWM)8 minutesA measure of the key aspects of working memory and storage of information over short periods of time.
Neuropsychological Outcomes: Motor Screen Tasks (MOT)3 minutesMOT provides a general indication that psychomotor function is intact enough to proceed with more sophisticated cognitive testing:

Secondary

MeasureTime frameDescription
Neuropsychological Outcomes: MOT Mean Latency, MOT Total Correct, and MOT Total Errors10 minutesThis test is a general assessment of whether there are sensorimotor deficits or lack of comprehension. Outcome is measured by reaction time in milliseconds of the participant reaching out and touching the "X" correctly (in the middle of the X) on the tablet in response to the stimulus. The maximum score is 6000 milliseconds. The number of total correct touches and total errors in not touching correctly out of 10 are recorded. Ex: MOT mean latency = 927.9 ml +/- 131.43 ms; MOT Total Correct = 10; MOT Total Errors = 0.

Countries

United States

Contacts

CONTACTJudy R Wilson, PH.D.
jrwilson@exchange.uta.edu817-272-3128
CONTACTXiangli Gu, Ph.D.
xiangli.gu@uta.edu
PRINCIPAL_INVESTIGATORJudy R Wilson, Ph.D.

UTArlington

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026